Screening of SARS-CoV-2 antivirals through a cell-based RNA-dependent RNA polymerase (RdRp) reporter assay
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
Article activity feed
-
-
SciScore for 10.1101/2022.04.04.486994: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics not detected. Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources The mouse anti-Flag (M2, Sigma-Aldrich), and mouse anti-GAPDH (G8140, US Biological, Salem MA) antibodies were used in this study. anti-GAPDHsuggested: (US Biological Cat# G8140-01L, RRID:AB_2278712)After 3 weeks of selection, expanded clones were examined for the expression of Flag-tagged nsp12 (RdRp) by western blot using anti-Flag antibody. anti-Flagsuggested: NoneExperimental Models: Cell Lines Sentences Resources Establishment of the Stable cell lines: Permissive HEK293 cells were … SciScore for 10.1101/2022.04.04.486994: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics not detected. Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources The mouse anti-Flag (M2, Sigma-Aldrich), and mouse anti-GAPDH (G8140, US Biological, Salem MA) antibodies were used in this study. anti-GAPDHsuggested: (US Biological Cat# G8140-01L, RRID:AB_2278712)After 3 weeks of selection, expanded clones were examined for the expression of Flag-tagged nsp12 (RdRp) by western blot using anti-Flag antibody. anti-Flagsuggested: NoneExperimental Models: Cell Lines Sentences Resources Establishment of the Stable cell lines: Permissive HEK293 cells were transfected with RdRp-luciferase reporter and pcDNA3.1. HEK293suggested: CLS Cat# 300192/p777_HEK293, RRID:CVCL_0045)After 24h, cells were selected using 250ug/mL G418 (for 293/RdRp cell lines) or 250ug/mL G418 and 25ug/mL hygromycin (for 293/RdRp-nsp5,7,8,12-Flag cell lines). 293/RdRpsuggested: None293/RdRp-nsp5,7,8,12-Flagsuggested: NoneFor relative viral genome quantification post infection and compound treatment, control or USA-WA1/2020 virus was added onto the Vero E6 cells plated in a 24-well plate (100,000 cells per well) for 2h (37 °C and 5% CO2). Vero E6suggested: NoneRecombinant DNA Sentences Resources Establishment of the Stable cell lines: Permissive HEK293 cells were transfected with RdRp-luciferase reporter and pcDNA3.1. pcDNA3.1suggested: RRID:Addgene_79663)Software and Algorithms Sentences Resources The input samples and the IP samples were resuspended in 45μL of SDS-PAGE loading buffer and denatured at 95°C for 5 min, resolved by SDS-PAGE and western blotted onto a 0.45 μM nitrocellulose membrane using standard protocols (Bio-Rad Laboratories, Hercules, CA, United States). Bio-Rad Laboratoriessuggested: (Bio-Rad Laboratories, RRID:SCR_008426)The absolute half-maximal inhibitory concentrations (IC50) of dasabuvir for SARS-CoV-2 USA-WA1/2020 and B.1.617.2 were calculated, based on the amounts of residual virus in the supernatant at each concentration, using the Graphpad Prism™. 2.8. Plaque Assay: Vero E6 cells (100,000 cells/well) in 1mL medium were seeded in a 24-well culture plate for 2h (37 °C and 5% CO2). Graphpadsuggested: (GraphPad, RRID:SCR_000306)Statistical analyses were performed using Prism 8.0 software (GraphPad Inc.). Prismsuggested: (PRISM, RRID:SCR_005375)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-
